Aurobindo Pharma Falls Over 16% After USFDA Recalls VIA On Hyderabad Plant

On Monday, shares of Aurobindo Pharma fell over 16 percent to an intraday low of Rs 489.40 after the US FDA rescinded the 'Voluntary Action Indicated' (VAI) status on one of its plants on 21 February. The Food and Drug

from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/2PilQPB